WENDELL WU: Open Payments
NPI 1841498193 · ALEXANDRIA, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$314 in 12 payments from 7 companies in 2025. Trend: 2023 $52 · 2024 $336 · 2025 $314
Food & beverage: $314
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 4 | $93 |
| Teva Pharmaceuticals USA, Inc. | 3 | $89 |
| Otsuka America Pharmaceutical, Inc. | 1 | $32 |
| Neurocrine BioSciences, Inc. | 1 | $26 |
| Janssen Pharmaceuticals, Inc | 1 | $26 |
| E.R. Squibb & Sons, L.L.C. | 1 | $25 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $23 |
Products named: UZEDY, ARISTADA, VIVITROL, ABILIFY ASIMTUFII, AUSTEDO XR, INGREZZA, INVEGA SUSTENNA, COBENFY.
Industry payments across VA — which companies pay providers there.
